首页 > 市场调查报告书 > 医疗设备

透析机设备

市场调查报告书

商品编码

1606496

日本透析设备市场 - 2024-2031

Japan Dialysis Equipment Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

日本透析设备市场在2023年达到28亿美元，预计2031年将达到40.6亿美元，在2024-2031年预测期间复合年增长率为4.5%。

透析机是一种在血液透析过程中过滤血液、维持电解质平衡和温度的医疗设备。透析机是一种混合和监测称为透析液的液体的设备，透析液可去除血液中的废物并保持电解质和矿物质的适当水平。它还可以监测体外的血流，并可能发出警报以提醒使用者进行任何必要的检查。

市场动态：

驱动程式和限制

科技进步的崛起

日本透析设备市场受到技术进步的推动，提高了患者的治疗效果和营运效率。日本的医疗技术创新带来了即时监控、自动液体平衡以及透析设备中人工智慧和物联网的整合。这些进步最大限度地减少了慢性肾臟病患者的併发症并提高了生活品质。

便携式和家用透析系统也越来越受欢迎。生物相容性透析器和高性能薄膜提高了过滤效率并减少了不良反应。日本製造商与学术机构合作，开发适合当地医疗保健需求的可靠系统。

例如，日本研究人员团队创造了一种便携式透析系统，高30厘米、宽18厘米、深12厘米，包括电池重3至4公斤。该设备旨在在灾难期间难以获得医疗服务时充当救生员。该设备比传统的便携式透析机小得多。

此外，远端监控和预测分析等数位健康技术正在彻底改变透析管理，从而实现早期干预和更好的资源利用。这些技术进步使日本成为透析护理领域的领导者，建立了全球基准并推动了国内成长。

设备成本高

儘管日本拥有先进的医疗基础设施和对肾臟护理服务的高需求，但由于设备成本高昂，日本的透析设备市场仍面临严重限制。初始投资和持续的维护费用给医疗保健提供者带来了财务挑战，尤其是小型诊所和农村设施。日本的全民健保制度和报销政策缓解了患者的一些经济压力，但营运费用仍然是一个障碍。透过具有成本效益的创新、政府补贴或合作伙伴关係来解决这一限制可以确保日本透析行业更广泛的可及性和市场成长。

例如，Nipro 透析机是医院、诊所和诊断中心使用的医疗设备，用于在肾臟无法净化血液时过滤血液。印度的平均价格在 1223995-1500000 日圆之间，具体取决于机器类型、吞吐量、容量、高级功能、配件和型号。这些机器可以从医院商店在线购买。

A dialysis machine is a medical device that filters blood during hemodialysis procedures, maintaining electrolyte balance and temperature. The dialysis machine is a device that mixes and monitors the fluid called dialysate, which removes waste products from the blood and maintains proper levels of electrolytes and minerals. It also monitors blood flow outside the body and may sound an alarm to alert the user of any necessary checks.

Market Dynamics: Drivers & Restraints

Rise in the Technological Advancements

The Japan dialysis equipment market is driven by technological advancements, enhancing patient outcomes and operational efficiency. Japan's medical technology innovation has led to real-time monitoring, automated fluid balancing, and integration with AI and IoT in dialysis devices. These advancements minimize complications and improve the quality of life for patients with chronic kidney disease.

Portable and home-based dialysis systems are also gaining traction. Biocompatible dialyzers and high-performance membranes have improved filtration efficiency and reduced adverse reactions. Japanese manufacturers, collaborating with academic institutions, develop reliable systems tailored to local healthcare needs.

For instance, a team of Japanese researchers have created a portable dialysis system that is 30 centimeters tall, 18 cm wide, and 12 cm deep, weighing 3 to 4 kilograms, including batteries. The device is designed to be a life-saver during disasters when medical care is difficult to access. The device is significantly smaller than conventional portable dialysis machines.

Moreover, digital health technologies like telemonitoring and predictive analytics are revolutionizing dialysis management, allowing early intervention and better resource utilization. These technological strides position Japan as a leader in dialysis care, setting global benchmarks and driving domestic growth.

High Cost of the Equipment

Japan's dialysis equipment market faces significant restraint due to the high cost of equipment, despite the country's advanced healthcare infrastructure and high demand for renal care services. Initial investments and ongoing maintenance expenses pose financial challenges for healthcare providers, especially smaller clinics and rural facilities. Japan's universal healthcare system and reimbursement policies alleviate some financial strain for patients, but operational expenses remain a barrier. Addressing this restraint through cost-effective innovations, government subsidies, or partnerships could ensure broader accessibility and market growth in Japan's dialysis sector.

For instance, A Nipro dialysis machine is a medical device used in hospitals, clinics, and diagnostic centers to filter blood when kidneys cannot purify it. The average price in India is between 1223995-1500000 Japan Yen, depending on machine type, throughput, capacity, advanced features, accessories, and models. These machines can be purchased online from hospital stores.

Segment Analysis

The Japan dialysis equipment market is segmented based on product type, disease condition and end user.

Product Type:

Hemodialysis Devices segment is expected to dominate the dialysis equipment market share

The hemodialysis devices segment holds a major portion of the dialysis equipment market share and is expected to continue to hold a significant portion of the dialysis equipment market share during the forecast period.

Japan has seen a significant growth in the end-stage renal disease hemodialysis devices market due to innovative dialyzing systems. The country has one of the highest per capita dialysis patients globally, emphasizing the importance of efficient devices for the elderly population. Hemodialysis devices help patients clean blood from harmful substances like toxins, waste, and excess water due to kidney failure.

The Japan market is characterized by high-tech machines with accuracy, reliability, and patient safety. Advancements in real-time monitoring, automatic functions, and easy navigation have driven the adoption of hemodialysis equipment. Local players understand local market demands, dominating the market, while international players bring better technologies and quality. The use of AI and IoT devices in hemodialysis machines is also increasing due to improved treatment protocols and results. Government policies and reimbursement systems also contribute to the market for hemodialysis devices in Japan.

Hospitals segment is the fastest-growing segment in the dialysis equipment market share

The hospitals segment is the fastest-growing segment in the dialysis equipment market share and is expected to hold the market share over the forecast period.

Japan's hospitals are key providers of hemodialysis services, offering comprehensive services like patient monitoring, emergency care, and individualized treatment plans. With a universal healthcare system and specialized nephrology departments, hospitals are central to delivering dialysis treatments to the growing patient population.

They provide state-of-the-art equipment, support cutting-edge technologies, and facilitate research and clinical trials. Japan's hospitals maintain rigorous standards for infection control and patient safety, ensuring the dialysis process adheres to the highest quality benchmarks. Urban hospitals house larger dialysis centers, while rural hospitals work towards expanding accessibility. Government funding and insurance coverage encourage patients to seek care from these well-equipped facilities. As chronic kidney disease burdens rise, hospitals will continue to drive the growth and evolution of the dialysis equipment market in Japan.

Competitive Landscape

The major Japan players in the dialysis equipment market include T Nikkiso Co., Ltd, Fresenius Medical Care Japan K.K, Kawasumi Laboratories, Inc, Asahi Kasei Medical Co., Ltd., Toray Medical Co., Ltd., Terumo Corporation,Nipro Corporation, JMS Co., Ltd among others.

Emerging Players

The emerging players in the dialysis equipment market include Medikit Co., Ltd, Sanritsu Corporation, Hitachi Healthcare Systems, Kyowa Hakko Kirin Co., Ltd and among others.

Key Developments

In September 2022, WEGO Terumo, a joint venture between WEGO and Terumo, has received regulatory approval from the National Medical Products Administration to manufacture and market a new neutral peritoneal dialysis solution.

Why Purchase the Report?

To visualize the Japan dialysis equipment market segmentation based on product type, disease condition, end user and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the dialysis equipment market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.

The Japan dialysis equipment market report would provide approximately 70 tables, 65 figures, and 184 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Disease Condition
3.3. Snippet by End User

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Technological Advancements
4.2. Restraints
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Hemodialysis Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Peritoneal Dialysis Devices
6.4. Others

7. By Disease Condition

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Condition
- 7.1.2. Market Attractiveness Index, By Disease Condition
7.2. Chronic*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Acute

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics
8.4. Dialysis Centers
8.5. Ambulatory Surgical Centers
8.6. Homecare Settings

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Nikkiso Co., Ltd.*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
10.2. Fresenius Medical Care Japan K.K.
10.3. Kawasumi Laboratories, Inc.
10.4. Asahi Kasei Medical Co., Ltd.
10.5. Toray Medical Co., Ltd.
10.6. Terumo Corporation
10.7. Nipro Corporation
10.8. JMS Co., Ltd.

LIST NOT EXHAUSTIVE